Page 46 - product-manual
P. 46

TM/MC  TM/MC
                                                                                             REFERENCES (cont’d)






            Lin LC, Shen CC, Shen YC, Tsai TH. (2006). Anti-inflammatory neolignans from Piper kadsura. Journal of Natural Products. 69:842-4.

            Liu JH, Zschocke S, Reininger E, Bauer R. (1998). Inhibitory effects of Angelica pubescens f. biserrata on 5-lipoxygenase and cyclooxygenase. Planta Medica. 164:525-9.

            Mahajan SG, Mali RG, Mehta AA. (2007). Protective effect of ethanolic extract of seeds of Moringa oleifera Lam. against inflammation associated with development of
            arthritis in rats. Journal of Immunotoxicology. (1):39-47.

            Masuda T, Jitoe A, Isobe J, et al. (1993). Anti-oxidative and anti-inflammatory curcumin-related phenolics from rhizomes of Curcuma domestica. Phytochemistry. 32:1557-
            1560.

            Muangnoi C, Chingsuwanrote P, Praengamthanachoti P, et al. (2012). Moringa oleifera Pod inhibits inflammatory mediator production by lipopolysaccharide-stimulated
            RAW 264.7 murine macrophage cell lines. Inflammation. 35(2):445-55.

            Notarnicola A, Tafuri S, Fusaro L, et al. (2011). The “MESACA” study: methylsulfonylmethane and boswellic acids in the treatment of gonarthrosis. Advances in Therapy.
            28:894-906.

            Okuyama E, Nishimura S, Ohmori S, et al. (1993). Analgesic component of Notopterygium incisum Ting. Chemical &  Pharmaceutical Bulletin (Tokyo). 41:926-9.

            Pal A, Bawankule DU, Darokar MP, et al. (2011). Influence of Moringa oleifera on pharmacokinetic disposition of rifampicin using HPLC-PDA method: a pre-clinical study.
            Biomedical Chromatography. 25:641-5.

            Paliwal R, Sharma V. Pracheta, et al. (2011). Anti-nephrotoxic effect of administration of Moringa oleifera Lam in amelioration of DMBA-induced renal carcinogenesis in
            Swiss albino mice. Biology and Medicine. 3SI:27-35.

            Pandey G. (2011). Active Principles and Median Lethal Dose of Curcuma longa L. International Research Journal of Pharmacy. 2:239-241.

            Pavithra BH, Prakash N, Jayakumar K. (2009). Modification of pharmacokinetics of norfloxacin following oral administration of curcumin in rabbits. Journal of Veterinary
            Science. 10:293-7.

            Reichling J, Schmökel H, Fitzi J, (2004). Dietary support with Boswellia resin in canine inflammatory joint and spinal disease. Schweizer Archiv Tierheilkunde. 146:71-9.

            Safayhi H, Rall B, Sailer ER, Ammon HP. (1997). Inhibition by boswellic acids of human leukocyte elastase. The Journal of Pharmacology and Experimental Therapeutics.
            281:460-3.

            Siemoneit U, Pergola C, Jazzar B, et al. (2009). On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevance.
            European Journal of Pharmacology. 606:246-54.

            Singh GB, Atal CK. (1986). Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new nonsteroidal anti-inflammatory agent. Agents and Actions. 18:407-412.

            Somasundaram S, et al. (2002). Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Research. 62:3868-75.

            Sung YY, Yoon T, Jang JY, et al. (2011). Topical application of Rehmannia glutinosa extract inhibits mite allergen-induced atopic dermatitis in NC/Nga mice. Journal of
            Ethnopharmacology. 134:37-44.

            Teng CM, Lin CH, Ko FN, et al. (1994). The relaxant action of osthole isolated from Angelica pubescens in guinea-pig trachea. Naunyn-Schmiedeberg’s Archives of
            Pharmacology. 349(2):202-8.

            Tsai JY, Chou CJ, Chen CF, Chiou WF. (2003). Antioxidant activity of piperlactam S: prevention of copper-induced LDL peroxidation and amelioration of free radical-induced
            oxidative stress of endothelial cells. Planta Medica. 69:3-8.








                                                                                                    Antitis-VM TM       |  11
   41   42   43   44   45   46   47   48   49   50   51